Literature DB >> 14567631

Amino acid ester prodrugs of floxuridine: synthesis and effects of structure, stereochemistry, and site of esterification on the rate of hydrolysis.

Balvinder S Vig1, Philip J Lorenzi, Sachin Mittal, Christopher P Landowski, Ho-Chul Shin, Henry I Mosberg, John M Hilfinger, Gordon L Amidon.   

Abstract

PURPOSE: To synthesize amino acid ester prodrugs of floxuridine (FUdR) and to investigate the effects of structure, stereochemistry, and site of esterification of promoiety on the rates of hydrolysis of these prodrugs in Caco-2 cell homogenates.
METHODS: Amino acid ester prodrugs of FUdR were synthesized using established procedures. The kinetics of hydrolysis of prodrugs was evaluated in human adenocarcinoma cell line (Caco-2) homogenates and pH 7.4 phosphate buffer.
RESULTS: 3'-Monoester, 5'-monoester, and 3',5'-diester prodrugs of FUdR utilizing proline, L-valine, D-valine, L-phenylalanine, and D-phenylalanine as promoieties were synthesized and characterized. In Caco-2 cell homogenates, the L-amino acid ester prodrugs hydrolyzed 10 to 75 times faster than the corresponding D-amino acid ester prodrugs. Pro and Phe ester prodrugs hydrolyzed much faster (3- to 30-fold) than the corresponding Val ester prodrugs. Further, the 5'-monoester prodrugs hydrolyzed significantly faster (3-fold) than the 3',5'-diester prodrugs.
CONCLUSIONS: Novel amino acid ester prodrugs of FUdR were successfully synthesized. The results presented here clearly demonstrate that the rate of FUdR prodrug activation in Caco-2 cell homogenates is affected by the structure, stereochemistry, and site of esterification of the promoiety. Finally, the 5'-Val and 5'-Phe monoesters exhibited desirable characteristics such as good solution stability and relatively fast enzymatic conversion rates.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14567631     DOI: 10.1023/a:1025745824632

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  26 in total

Review 1.  Drug transport and targeting. Intestinal transport.

Authors:  D M Oh; H K Han; G L Amidon
Journal:  Pharm Biotechnol       Date:  1999

Review 2.  Targeted prodrug design to optimize drug delivery.

Authors:  H K Han; G L Amidon
Journal:  AAPS PharmSci       Date:  2000

3.  Current progress on esterases: from molecular structure to function.

Authors:  Tetsuo Satoh; Palmer Taylor; William F Bosron; Sonal P Sanghani; Masakiyo Hosokawa; Bert N La Du
Journal:  Drug Metab Dispos       Date:  2002-05       Impact factor: 3.922

4.  Transport of valganciclovir, a ganciclovir prodrug, via peptide transporters PEPT1 and PEPT2.

Authors:  M Sugawara; W Huang; Y J Fei; F H Leibach; V Ganapathy; M E Ganapathy
Journal:  J Pharm Sci       Date:  2000-06       Impact factor: 3.534

5.  A photoactivated prodrug.

Authors:  Y Wei; Y Yan; D Pei; B Gong
Journal:  Bioorg Med Chem Lett       Date:  1998-09-22       Impact factor: 2.823

6.  Selective anticancer effects of 3',5'-dioctanoyl-5-fluoro-2'-deoxyuridine, a lipophilic prodrug of 5-fluoro-2'-deoxyuridine, dissolved in an oily lymphographic agent on hepatic cancer of rabbits bearing VX-2 tumor.

Authors:  S Fukushima; T Kawaguchi; M Nishida; K Juni; Y Yamashita; M Takahashi; M Nakano
Journal:  Cancer Res       Date:  1987-04-01       Impact factor: 12.701

7.  Nonenzymatic and enzymatic hydrolysis of 5-fluoro-2'-deoxyuridine (FUdR) esters.

Authors:  T Kawaguchi; S Fukushima; Y Hayashi; M Nakano
Journal:  Pharm Res       Date:  1988-11       Impact factor: 4.200

8.  Synthesis and biological studies of novel nucleoside phosphoramidate prodrugs.

Authors:  S C Tobias; R F Borch
Journal:  J Med Chem       Date:  2001-12-06       Impact factor: 7.446

Review 9.  Prodrug strategies in cancer therapy.

Authors:  W A Denny
Journal:  Eur J Med Chem       Date:  2001 Jul-Aug       Impact factor: 6.514

10.  Cellular uptake mechanism of amino acid ester prodrugs in Caco-2/hPEPT1 cells overexpressing a human peptide transporter.

Authors:  H K Han; D M Oh; G L Amidon
Journal:  Pharm Res       Date:  1998-09       Impact factor: 4.200

View more
  26 in total

Review 1.  Amino Acids in the Development of Prodrugs.

Authors:  Nuno Vale; Abigail Ferreira; Joana Matos; Paula Fresco; Maria João Gouveia
Journal:  Molecules       Date:  2018-09-11       Impact factor: 4.411

2.  Selection of suitable prodrug candidates for in vivo studies via in vitro studies; the correlation of prodrug stability in between cell culture homogenates and human tissue homogenates.

Authors:  Yasuhiro Tsume; Gordon L Amidon
Journal:  J Pharm Pharm Sci       Date:  2012       Impact factor: 2.327

3.  Potential of amino acid/dipeptide monoester prodrugs of floxuridine in facilitating enhanced delivery of active drug to interior sites of tumors: a two-tier monolayer in vitro study.

Authors:  Yasuhiro Tsume; John M Hilfinger; Gordon L Amidon
Journal:  Pharm Res       Date:  2011-06-14       Impact factor: 4.200

Review 4.  N3-substituted thymidine bioconjugates for cancer therapy and imaging.

Authors:  Ahmed Khalil; Keisuke Ishita; Tehane Ali; Werner Tjarks
Journal:  Future Med Chem       Date:  2013-04       Impact factor: 3.808

5.  Bioavailability of the amino acid-attached prodrug as a new anti-HIV agent in rats.

Authors:  Kyung Ae Chae; Hee Jung Cho; Ji Min Sung; Hee Lee; Dong Cheol Seo; Jin Suk Kim; Ho Chul Shin
Journal:  J Vet Sci       Date:  2007-09       Impact factor: 1.672

Review 6.  Recent trends in targeted anticancer prodrug and conjugate design.

Authors:  Yashveer Singh; Matthew Palombo; Patrick J Sinko
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

7.  Synthesis, chemical and enzymatic hydrolysis, and aqueous solubility of amino acid ester prodrugs of 3-carboranyl thymidine analogs for boron neutron capture therapy of brain tumors.

Authors:  Sherifa Hasabelnaby; Ayman Goudah; Hitesh K Agarwal; Mosaad S M abd Alla; Werner Tjarks
Journal:  Eur J Med Chem       Date:  2012-07-27       Impact factor: 6.514

8.  The development of orally administrable gemcitabine prodrugs with D-enantiomer amino acids: enhanced membrane permeability and enzymatic stability.

Authors:  Yasuhiro Tsume; Tuba Incecayir; Xueqin Song; John M Hilfinger; Gordon L Amidon
Journal:  Eur J Pharm Biopharm       Date:  2013-12-19       Impact factor: 5.571

9.  Design and synthesis of vidarabine prodrugs as antiviral agents.

Authors:  Wei Shen; Jae-Seung Kim; Phillip E Kish; Jie Zhang; Stefanie Mitchell; Brian G Gentry; Julie M Breitenbach; John C Drach; John Hilfinger
Journal:  Bioorg Med Chem Lett       Date:  2008-12-10       Impact factor: 2.823

10.  Enhanced cancer cell growth inhibition by dipeptide prodrugs of floxuridine: increased transporter affinity and metabolic stability.

Authors:  Yasuhiro Tsume; John M Hilfinger; Gordon L Amidon
Journal:  Mol Pharm       Date:  2008-07-25       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.